Literature DB >> 3752973

Occurrence of clindamycin-resistant anaerobic bacteria isolated from cultures taken following clindamycin therapy.

M J Ohm-Smith, R L Sweet, W K Hadley.   

Abstract

MICs of clindamycin were determined by the agar dilution method against anaerobic organisms isolated from endometrial cultures in women with pelvic soft tissue infections. Cultures were obtained from 100 women both before and after clindamycin therapy, from 107 women before therapy with clindamycin or another antimicrobial agent or after treatment with an antimicrobial agent other than clindamycin, and from 9 women 1 to 9 weeks after they were discharged from the hospital following clindamycin therapy. Only 5 (0.7%) of 685 isolates tested from women who had not received clindamycin therapy were resistant to clindamycin. From the 100 cultures taken immediately after clindamycin therapy, 57 anaerobic bacteria were isolated from 28 cultures. Of the 40 anaerobic organisms for which MICs of clindamycin were determined, 25 (62.5%) were resistant to clindamycin (MIC greater than or equal to 8 micrograms/ml). The most common organisms isolated after therapy were the anaerobic gram-positive cocci (of which 32 isolates were discovered); of 28 coccal isolates tested, 64% were clindamycin resistant. Four of seven (57%) of the Bacteroides isolates tested, one unidentified gram-positive nonsporing rod, one unidentified gram-negative coccus, and one Mobiluncus sp. were also clindamycin resistant. Of 18 anaerobic isolates from the nine cultures taken 1 to 9 weeks after hospital discharge, 55% were resistant to clindamycin. The clinical significance of these findings is unknown since all patients recovered without incident and remained well. However, the data suggest that physicians need to be aware that patients with recent exposure to clindamycin may have clindamycin-resistant anaerobic organisms in a current infection. This may prevent the infection from responding to clindamycin treatment.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3752973      PMCID: PMC176425          DOI: 10.1128/AAC.30.1.11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  The effects of four antimicrobial drug regimens on sputum superinfection in hospitalized patients.

Authors:  D B LOURIA; T KAMINSKI
Journal:  Am Rev Respir Dis       Date:  1962-05

2.  Clindamycin in infections of the female genital tract.

Authors:  R M Swenson; T C Michaelson; M J Daly; E H Spalding
Journal:  Obstet Gynecol       Date:  1974-11       Impact factor: 7.661

3.  The effect of antibiotic prophylaxis on patients undergoing vaginal operations. II. Alterations of microbial flora.

Authors:  M J Ohm; R P Galask
Journal:  Am J Obstet Gynecol       Date:  1975-11-15       Impact factor: 8.661

4.  Moxalactam versus clindamycin plus tobramycin in the treatment of obstetric and gynecologic infections.

Authors:  R L Sweet; M Ohm-Smith; D V Landers; M O Robbie
Journal:  Am J Obstet Gynecol       Date:  1985-08-01       Impact factor: 8.661

5.  Susceptibility testing of clinically isolated anaerobic bacteria by an agar dilution technique.

Authors:  W J Brown; P E Waatti
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

6.  The effect of antibiotic prophylaxis on patients undergoing total abdominal hysterectomy. I. Effect on morbidity.

Authors:  M J Ohm; R P Galask
Journal:  Am J Obstet Gynecol       Date:  1976-06-15       Impact factor: 8.661

7.  In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens.

Authors:  W J Martin; M Gardner; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

8.  Susceptibility of anaerobic bacteria to 23 antimicrobial agents.

Authors:  V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

Review 9.  Clindamycin: a review of fifteen years of experience.

Authors:  V K Dhawan; H Thadepalli
Journal:  Rev Infect Dis       Date:  1982 Nov-Dec

10.  A double-blind, randomized comparison of clindamycin-gentamicin versus cefamandole for treatment of post-cesarean section endomyometritis.

Authors:  R S Gibbs; J D Blanco; Y S Castaneda; P J St Clair
Journal:  Am J Obstet Gynecol       Date:  1982-10-01       Impact factor: 8.661

View more
  4 in total

Review 1.  Beta-lactamase inhibitors from laboratory to clinic.

Authors:  K Bush
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

2.  Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole.

Authors:  M N Austin; R H Beigi; L A Meyn; S L Hillier
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 3.  Gram-positive anaerobic cocci.

Authors:  D A Murdoch
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

4.  Resistance of Peptostreptococcus spp. to macrolides and lincosamides: inducible and constitutive phenotypes.

Authors:  M Reig; A Moreno; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.